A Non-Traumatic Binder for Temporary Abdominal Wall Closure
Launched by UNITY HEALTH TORONTO · Jan 23, 2019
Trial Information
Current as of May 21, 2025
Unknown status
Keywords
ClinConnect Summary
At the end of most abdominal operations the fascial layer is closed primarily. However, because of logistic, physiological and or anatomical reasons, the surgeon needs to leave the abdomen open. In those circumstances, attempts to close the abdomen could potentially lead to unnecessary damage to the abdominal wall fascia, intra-abdominal hypertension, abdominal compartment syndrome and abdominal wall dehiscence post-operatively.
The use of the "open abdomen" (OA) in the post-operative period is not uncommon. Currently, three important trends provide grounds for increased use of this surgic...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Mechanically ventilated patients, managed with the OA strategy.
- • 16 years of age or older
- Exclusion Criteria:
- • Patients who are pregnant
- • Loss of any portion of the abdominal wall that could preclude primary closure
- • Burn patients
- • BMI greater than 40 kg/m2
About Unity Health Toronto
Unity Health Toronto is a leading healthcare organization dedicated to providing exceptional patient care, advancing medical research, and fostering education in the field of health sciences. Comprising St. Michael's Hospital, St. Joseph's Health Centre, and Providence Healthcare, Unity Health integrates a diverse range of clinical services and innovative research initiatives. The organization is committed to improving health outcomes through collaborative partnerships and community engagement, while upholding the highest standards of ethics and integrity in its clinical trials and research endeavors. By focusing on patient-centered approaches, Unity Health Toronto aims to drive advancements in healthcare and contribute to the well-being of the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Toronto, Ontario, Canada
New Westminster, British Columbia, Canada
Halifax, Nova Scotia, Canada
Patients applied
Trial Officials
Joao Rezende-Neto, MD
Principal Investigator
Unity Health Toronto
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials